• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Free ACCA & CIMA online courses from OpenTuition

Free ACCA & CIMA online courses from OpenTuition

Free Notes, Lectures, Tests and Forums for ACCA and CIMA exams

  • ACCA
  • CIMA
  • FIA
  • OBU
  • Books
  • Forums
  • Ask AI
  • Search
  • Register
  • Login
  • ACCA Forums
  • Ask ACCA Tutor
  • CIMA Forums
  • Ask CIMA Tutor
  • FIA
  • OBU
  • Buy/Sell Books
  • All Forums
  • Latest Topics

20% off ACCA & CIMA Books

OpenTuition recommends the new interactive BPP books for March and June 2025 exams.
Get your discount code >>

Convertible Loan Treatment

Forums › ACCA Forums › ACCA SBR Strategic Business Reporting Forums › Convertible Loan Treatment

  • This topic has 0 replies, 1 voice, and was last updated 8 years ago by silviatro.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • July 27, 2016 at 10:53 am #329833
    silviatro
    Member
    • Topics: 4
    • Replies: 2
    • ☆

    Hello there,
    Can anyone help with the following scenario?
    I am not entirely sure on the accounting treatment / double entry:

    SCENARIO

    On 15th May 20X5 Company A issues a cash loan of $40,000 accruing interest at 5%. [ is this a zero-coupon loan?]

    The Company will also issue to the same lender a Warrant to purchase a number of common shares in the company equal to the number of $ lent. The Warrant has an exercise price of $0.50 paid over 5 years.

    The loan will have to be repaid in full plus accrued interest no later than 31st Aug 20X5.

    The warrant entitles the lender to purchase from the issuer up to 10,000 fully-paid & non-assessable shares at the price of $0.50 per share.
    The warrant is exercisable on 15th 20Y0.

    So my questions are:

    1) is it correct to discount the interest of $2,000 [40k x 5%] up to year 4 and at year 5 discount the whole $40k?
    By doing so I obtain a liability of $38,432.95, which means the equity element [share option] comes to $1,567.05.

    My dbl entries being:
    15th May 20×5

    Dr Bank $40K
    Cr Liability $38,432.95
    Cr Equity Share Option $1,567.05

    2) Do I then amortise the liability of $38,432.95 [opening bal] calculating interest @ 5%
    [do I time apportion this being the loan issued on 15th May 20X5, $892.57? or do I keep it in full , $1921.65?]

    3) [and this is where I am not sure at all]
    since this seems to be a zero-coupon conv. loan I don’t have any cash paid [3rd column of my calcs] to subtract from the liability of $38,432.95 less interest.
    Do I then carry on with the amortisation of the loan until year 5? If not how should I calculate this?
    If I do what is the year 5 interest & Cash paid?

    4) as per the warrant this comes to $5,000, right? 10,000 shares @ $0.50.
    The dbl entry for this will be:

    Dr Liability $5K [effectively it reduces my liability of $38,432.95, right?]
    Cr Warrant $5K [will this sit in my reserves under “Warrant”?]

    Sorry for the lengthy message – I hope someone can help.

    Thanks,

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.
Log In

Primary Sidebar

Donate
If you have benefited from our materials, please donate

ACCA News:

ACCA My Exam Performance for non-variant

Applied Skills exams is available NOW

ACCA Options:  “Read the Mind of the Marker” articles

Subscribe to ACCA’s Student Accountant Direct

ACCA CBE 2025 Exams

How was your exam, and what was the exam result?

BT CBE exam was.. | MA CBE exam was..
FA CBE exam was.. | LW CBE exam was..

Donate

If you have benefited from OpenTuition please donate.

PQ Magazine

Latest Comments

  • azubair on PM Chapter 15 Questions Financial Performance Measurement
  • Dileena on Sources of finance – Islamic Finance – ACCA (AFM) lectures
  • amaanalli on Governance – ACCA Strategic Business Leader (SBL)
  • nabeelafatima on Using Information Systems – ACCA Performance Management (PM)
  • John Moffat on Irrecoverable Debts and Allowances Example 3 – ACCA Financial Accounting (FA) lectures

Copyright © 2025 · Support · Contact · Advertising · OpenLicense · About · Sitemap · Comments · Log in